Alnylam Pharmaceuticals, Inc. (ALNY)

338.15 +5.15 (+1.55%) USD  |  NASDAQ  |  Apr 14, 15:49
More

Alnylam Pharmaceuticals Total Operating Expenses (TTM)

Total Operating Expenses (TTM) Chart

View Total Operating Expenses (TTM) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (TTM) Range, Past 5 Years

View Total Operating Expenses (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (TTM) Benchmarks

View Total Operating Expenses (TTM) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade